PulseSelect PFA Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
Status: Recruiting
Location: See all (15) locations...
Study Type: Observational
SUMMARY
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is ≥ 18 years of age or minimum age as required by local regulations.
• Subject has been diagnosed with atrial fibrillation (AF)
• Planned procedure using commercially available PulseSelect™ PFA System.
• Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.
Locations
Other Locations
Canada
McGill University Health Centre (MUHC)
RECRUITING
Montreal
Vancouver General Hospital
RECRUITING
Vancouver
France
Centre Hospitalier Universitaire de Grenoble - Site Nord
RECRUITING
Grenoble
Hôpital Privé Jacques Cartier
RECRUITING
Massy
Germany
Asklepios Klinik St Georg
NOT_YET_RECRUITING
Hamburg
St. Vincenz-Krankenhaus Paderborn
RECRUITING
Paderborn
Italy
IRCCS Ospedale Sacro Cuore Don Calabria
RECRUITING
Negrar Di Valpolicella
Netherlands
St Antonius Ziekenhuis
RECRUITING
Nieuwegein
Poland
Centralny Szpital Kliniczny Uniwersytetu Medyczneg
NOT_YET_RECRUITING
Lódź
Republic of Korea
Seoul National University Bundang Hospital
RECRUITING
Seongnam-si
Samsung Medical Center
RECRUITING
Seoul
Severance Hospital
RECRUITING
Seoul
Spain
Complejo Asistencial Universitario de Salamanca
RECRUITING
Salamanca
United Kingdom
Basildon and Thurrock University Hospitals
NOT_YET_RECRUITING
Basildon
University Hospitals Coventry & Warwickshire
NOT_YET_RECRUITING
Coventry
Contact Information
Primary
Josman Suri
josman.suri@medtronic.com
7635050262
Time Frame
Start Date: 2024-07-23
Estimated Completion Date: 2027-07-01
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: Medtronic Cardiac Ablation Solutions